We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.1B
1-Year Est. Return
8.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.4B
AUM Growth
-$200M
(-4.3%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
21.56%
Holding
225
New
15
Increased
38
Reduced
133
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$32M |
| 2 |
Boston Scientific
BSX
|
+$23M |
| 3 |
Vulcan Materials
VMC
|
+$9.52M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$7.8M |
| 5 |
Polaris
PII
|
+$7.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AptarGroup
ATR
|
+$31.6M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$29.7M |
| 3 |
AGN
Allergan plc
AGN
|
+$24.4M |
| 4 |
Merck
MRK
|
+$21.6M |
| 5 |
Cisco
CSCO
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Healthcare | 15.73% |
| 3 | Financials | 15.43% |
| 4 | Industrials | 14.88% |
| 5 | Consumer Discretionary | 14.75% |
Similar funds
VT
CS
EIC
AC
CIA
TAM
CTC
BG
Nicholas Company's Q1 2018 Portfolio in Review
As of Q1 2018, Nicholas Company held 225 positions worth $4.4B, down 4.3% from $4.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nicholas Company withdrew a net $224M in Q1 2018, closing 14 positions and reducing 133 holdings. Its most notable exit was Allergan plc, an estimated $9.65M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nicholas Company opened a new position in Honeywell worth $30.2M.
- Nicholas Company's largest Q1 2018 buy was Honeywell: 231,357 shares worth $30.2M.
- Nicholas Company added most to Albemarle in Q1 2018, an estimated $6.65M increase.
- Nicholas Company's biggest Q1 2018 reduction was AptarGroup, cutting an estimated $31.6M.
- Nicholas Company fully exited Allergan plc in Q1 2018, selling an estimated $9.65M.
- Nicholas Company's ten largest holdings make up 22% of its $4.4B portfolio in Q1 2018.
- Nicholas Company opened 15 new positions and closed 14 in Q1 2018.
- Nicholas Company's portfolio value fell 4.3% quarter-over-quarter to $4.4B.
Based on Nicholas Company's 13F filing for Q1 2018, filed 14 May 2018.